
    
      This is a Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a
      Study to evaluate the Efficacy and Safety of Oral AMT-101 in Subjects with Moderate to Severe
      Ulcerative Colitis.
    
  